The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas
Open accessAbstract
BACKGROUND: Epidemiologic and preclinical data suggest that higher intake and serum levels of vitamin D and higher intake of calcium reduce the risk of colorectal neoplasia. To further study the chemopreventive potential of these nutrients, we conducted a randomized, double-blind, placebo-controlled trial of supplementation with vitamin D, calcium, or both for the prevention of colorectal adenomas. METHODS: We recruited patients with recently diagnosed adenomas and no known colorectal polyps remaining after complete colonoscopy. We randomly assigned 2259 participants to receive daily vitamin D3 (1000 IU), calcium as carbonate (1200 mg), both, or neither in a partial 2×2 factorial design. Women could elect to receive calcium plus random assignment to vitamin D or placebo. Follow-up colonoscopy was anticipated to be performed 3 or 5 years after the baseline examinations, according to the endoscopist's recommendation. The primary end point was adenomas diagnosed in the interval from randomization through the anticipated surveillance colonoscopy. RESULTS: Participants who were randomly assigned to receive vitamin D had a mean net increase in serum 25-hydroxyvitamin D levels of 7.83 ng per milliliter, relative to participants given placebo. Overall, 43% of participants had one or more adenomas diagnosed during follow-up. The adjusted risk ratios for recurrent adenomas were 0.99 (95% confidence interval [CI], 0.89 to 1.09) with vitamin D versus no vitamin D, 0.95 (95% CI, 0.85 to 1.06) with calcium versus no calcium, and 0.93 (95% CI, 0.80 to 1.08) with both agents versus neither agent. The findings for advanced adenomas were similar. There were few serious adverse events. CONCLUSIONS: Daily supplementation with vitamin D3 (1000 IU), calcium (1200 mg), or both after removal of colorectal adenomas did not significantly reduce the risk of recurrent colorectal adenomas over a period of 3 to 5 years. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT00153816.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deciding how to balance external and internal validity is a challenge for many trials 52, but is particularly salient for trials of DHI.”
From Evaluating Digital Health Interventions (2016) · cites this paper as [52]
In the citing paper
“However, there are real questions as to how well approaches developed to reduce bias in drug trials translate to trials of complex interventions in general 52 and to digital interventions in particular, including concerns about the degree to which design features that enhance internal validity jeopardise external validity.”
From Evaluating Digital Health Interventions (2016) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Norman, A. W. (1979) · Cited by 3,769
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial
Lappe, J. M., Travers‐Gustafson, D., Davies, K. M., Recker, R. R., & Heaney, R. P. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.6.1586 · Cited by 1,445
The role of vitamin D in reducing cancer risk and progression
Feldman, D., Krishnan, A. V., Swami, S., Giovannucci, E. L., & Feldman, B. J. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3691 · Cited by 1,351
Trivedi, D. P., Doll, R., & Khaw, K. (2003) · BMJ · doi:10.1136/bmj.326.7387.469 · Cited by 1,273
Bolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., & Reid, I. R. (2010) · BMJ · doi:10.1136/bmj.c3691 · Cited by 1,099
Self-citationCalcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer
Wactawski‐Wende, J., Kotchen, J. M., Anderson, G. L., Assaf, A. R., Brunner, R. L., O’Sullivan, M. J., Margolis, K. L., Ockene, J. K., Phillips, L. S., Pottern, L. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055222 · Cited by 980
Calcium Supplements for the Prevention of Colorectal Adenomas
Baron, J. A., Beach, M. A., Mandel, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R. I., Summers, R. W., Snover, D. C., Beck, G. J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400204 · Cited by 865
Self-citationGandini, S., Boniol, M., Haukka, J. K., Byrnes, G. B., Cox, B., Sneyd, M. J., Mullie, P., & Autier, P. (2010) · International Journal of Cancer · doi:10.1002/ijc.25439 · Cited by 504
Bonithon‐Kopp, C., Kronborg, O., Giacosa, A., Räth, U., & Faivre, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02813-0 · Cited by 475
Chung, M., Lee, J., Terasawa, T., Lau, J., & Trikalinos, T. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-12-201112200-00005 · Cited by 421
Flagged first, then by citations
Research works printed but not linked: 2
- Brown AJ, 1999, Am J Physiol, 277, F157
- Institute of Medicine Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academies Press, 1997.
Cited by
Sorted by citations
Items 301–314 of 314
Vitamin D and the immune system
Zulkipli, I. N., & Ahmad, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34037-6.00033-9
Vaughan-Shaw, P. G., Grimes, G., Blackmur, J. P., Timofeeva, M., Walker, M., Ooi, L. Y., Svinti, V., Donnelly, K., Din, F. V. N., Farrington, S. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15094870
Vaughan-Shaw, P. G., Grimes, G., Blackmur, J. P., Timofeeva, M., Walker, M., Ooi, L. Y., Svinti, V., Donnelly, K., Din, F. V. N., Farrington, S. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15094876
Veettil, S. K., Kew, S. T., Lim, K. G., Phisalprapa, P., Kumar, S., V, Lee, Y. Y., & Chaiyakunapruk, N. (2021) · Figshare · doi:10.6084/m9.figshare.14254025
Vaughan-Shaw, P. G., Grimes, G., Blackmur, J. P., Timofeeva, M., Walker, M., Ooi, L. Y., Svinti, V., Donnelly, K., Din, F. V. N., Farrington, S. M., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15094879
Seal, S., Fanning, L. R., Bagley, E. M., Bookhout, C. E., Barry, E. L., O’Quinn, E. C., Snover, D. C., Lewin, D., Guglietta, S., Kourtidis, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.06.697786
Self-citationEinnahme von nativem Vitamin D in der Allgemeinbevölkerung
Essigke, D. (2026) · Nephrologie aktuell · doi:10.1055/a-2703-6887
Use of Calcitriol in Colorectal Cancer Treatment
Tunçer, S. (2026) · Journal of the Institute of Science and Technology · doi:10.21597/jist.1654927
Tao, X., & Yao, J. (2026) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/cjgh/2782582
Seal, S., Fanning, L. R., Bagley, E. M., Bookhout, C. E., Barry, E. L., O’Quinn, E. C., Snover, D. C., Lewin, D., Guglietta, S., Kourtidis, A., et al. (2026) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-26-0083
Self-citationSuzuki, T., Matsuura, K., Narahara, S., Okayama, K., Okumura, F., Sobue, S., Narita, K., Mizoshita, T., Kondo, H., Kimura, Y., et al. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-026-03114-y
Anton, A., Brebu, D. A., Bugi, M.-A., Neamțu, A.-A., Căpraru, A.-M., Zurbău-Anghel, N., Iovănescu, D., Maghiar, T. A., Pașca, P., Faur, F. I., et al. (2026) · Diagnostics · doi:10.3390/diagnostics16203386
Vitamin D in Digestive Neoplasms: Molecular Mechanisms and Clinical Evidence
Treteanu, A. R., Stănescu, A. M. A., Constantinescu, A., Băjenaru, O., Nuță, C. R., Pîrcălăbioru, G. G., & Andronic, O. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209343
Metadata
- Authors
- Baron, J. A., Barry, E. L., Mott, L. A., Rees, J. R., Sandler, R. S., Snover, D. C., Bostick, R. M., Ivanova, A., Cole, B. F., Ahnen, D. J., Beck, G. J., Bresalier, R. S., Burke, C. A., Church, T. R., Cruz-Correa, M., Figueiredo, J. C., Goodman, M., Kim, A. S., Robertson, D. J., Rothstein, R., Shaukat, A., Seabrook, M. E., & Summers, R. W.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Fairview Southdale Hospital (US)
- Emory University (US)
- University of Vermont (US)
- Cleveland Clinic (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Minnesota (US)
- University of Southern California (US)
- MNGI Digestive Health (US)
- Dartmouth–Hitchcock Medical Center (US)
- University of Iowa (US)
- ORCID
- Baron, John A.
- Barry, Elizabeth L.
- Mott, Leila A.
- Rees, Judy R.
- Sandler, Robert S.
- Snover, Dale C.
- Bostick, Roberd M.
- Ivanova, Anastasia
- Cole, Bernard F.
- Ahnen, Dennis J.
- Beck, Gerald J.
- Bresalier, Robert S.
- Burke, Carol A.
- Church, Timothy R.
- Figueiredo, Jane C.
- Goodman, Michael
- Kim, Adam S.
- Robertson, Douglas J.
- Shaukat, Aasma
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-10-15
- Volume
- 373
- Issue
- 16
- Pages
- 1519-1530
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4643064
- OpenAlex
- W2259846353
- Cited by
- 315
- References
- 26
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 15 · 2023: 26 · 2022: 29 · 2021: 32 · 2020: 29 · 2019: 39 · 2018: 36 · 2017: 33 · 2016: 49 · 2015: 3
- FWCI
- 32.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA098286, CA098286, P30CA023108)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056338)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- colorectal adenoma, vitamin D3 supplementation, calcium supplementation, chemoprevention, recurrent adenoma, advanced adenoma, serum 25-hydroxyvitamin D, colorectal neoplasia, surveillance colonoscopy
- MeSH terms
- Adenoma, Aged, Calcium, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Risk, Vitamin D, Vitamins, Colorectal Neoplasms, Treatment Failure, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
